Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update
SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today reported financial results for the quarter ended ...
Dare Bioscience Inc (DARE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
Dare Bioscience Inc (DARE) secures significant funding and progresses with FDA interactions, despite facing increased ...
Daré Bioscience, Inc.: Daré Bioscience Reports Third Quarter 2024 Financial Results and ...
Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone-free monthly intravaginal contraceptive candidate - pivotal Phase 3 contra ...
Q3 2024 Dare Bioscience Inc Earnings Call
Layton; Chief Accounting Officer; Dare Bioscience Inc. Sabrina Johnson; President, Chief Executive Officer, Secretary, Director; Dare Bioscience Inc. C ...